Project measures / variables set:   CSNA03   trial_init_latency_in_Binghamton

ID, description, units MPD:112885   trial_init_latency_in_Binghamton   mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders   [centiseconds/n]  
Measures
• acquisition    • reversal
Data set, strains CSNA03   inbred w/CC8   8 strains     sex: both     age:
Procedure operant conditioning chamber
Comparisonrepeated measures other progression, same cohort
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options
Advanced Plot Options
Separate Plot Factor(s)
Legend Factor(s)
X-Axis Factor(s)
Include/Exclude Factor Values

CSNA03 - mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders






  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested
SexAge
CSNA03 112885 operant conditioning chamber (none) mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders   [centiseconds/n]   acquisition  trial_init_latency_in_acq_Binghamton inbred w/CC8 8 both
CSNA03 112886 operant conditioning chamber (none) mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders   [centiseconds/n]   reversal  trial_init_latency_in_rev_Binghamton inbred w/CC8 8 both